Home > News > Intel charts new seas
November 21st, 2003
Intel charts new seas
For the first time, Intel Corp. has made available its chip-making nanotechnology tools to cancer researchers in the hope that being able to detect tiny defects in silicon chips also will work in human tissue to diagnose and study cancer. Though just preliminary research, Intel's union with the Fred Hutchinson Cancer Research Center in Seattle is part of a voyage toward its future beyond pure-silicon manufacturing. After all, Intel's advanced chips will be commodities within several years, say experts.
Patent for the Novel Cancer Therapies – Ceramide Nanoliposomes March 4th, 2015
Arrowhead to Present at 2015 Barclays Global Healthcare Conference March 4th, 2015
Democratizing synthetic biology: New method makes research cheaper, faster, and more accessible March 3rd, 2015
Pens filled with high-tech inks for do-it-yourself sensors March 3rd, 2015